Real time fluorescent quantitative polymerase chain reaction (RT–qPCR), immunohistochemical (IHC) and flow cytometry (FCM) were used to further confirm the expression pattern of SEMA4D in TME and to explore the effect of SEMA4D in tumor-infiltrating lymphocytes. The gene discussed is SEMA4D; the disease is neoplasm.